A new form of male contraceptive is being tested. No, it's not another kind of condom, and it isn't a male pill. The new birth control form is actually an injection called Vasalgel, and it could be debuting on the market as soon as 2017.

From the Parsemus Foundation, Vasalgel is hormone-free gel that is injected directly above the testicles. It then temporarily blocks sperm flow through the vas deferens tubes, similar to a vasectomy. However, this procedure is reversible.

The blocked flow, which does not harm the male individual, can be reversed by a second injection months or even years later. The secondary compound clears out the Vasalgel, restoring sperm flow.

Testing on animals like baboons and rabbits so far has had promising results, and injections could be cleared for human testing in 2015. However, getting approval in the scientific arena is only one element of the issue; the social acceptance of this contraceptive method is critical to its success.

"I don't think men will opt for it," Donna Dawson told the Telegraph. Dawson is a psychologist specializing in behavior, and seems assured that no man will want the procedure.

"They'll either say it's the women's job, or they'll be too squeamish," she added. "They're not used to taking that amount of responsibility for birth control. They don't have the pain threshold women have...Women are more conditioned and acclimatized to taking birth control. Men have had no experience of it. Most men won't even have the snip, making most women have their tubes tied instead."

Parsemus also said via their website that the price for the Vasalgel will be fairly reasonable.

"A contraceptive shouldn't cost more than a flat-screen TV," the message said. "It is likely that the cost for the doctor visit will be more than for [Vasalgel]."

However, this may give pharmaceutical companies an incentive to stop Vasalgel from being released, as this would cost them millions in female oral contraceptive sales.